Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 16.2B | 16.4B | 15.2B | 16.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 8.5B | 8.2B | 8.4B | 8.4B |
| Other operating expenses | 4.3B | 4.6B | 5.1B | 2.0B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.5B | 3.5B | 1.6B | 5.7B |
| Tax provision | 852M | 1.4B | 399M | 1.9B |
| Net income | 2.6B | 2.0B | 1.2B | 3.7B |
| Basic EPS | — | — | — | 129.3 |
| Diluted EPS | — | — | — | 129.3 |
| Basic average shares | — | — | — | 28.9M |
| Diluted average shares | — | — | — | 28.9M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |